ImageneBio Inc (IMA) financial statements and ratios from SEC XBRL: revenue $800000.00 (TTM), net margin -5668.6%, revenue growth -77.1% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $800000.00 |
| Net Margin | -5668.6% |
| Revenue Growth (YoY) | -77.1% |
| EPS Growth (YoY) | 845.1% |
| Price / Book | 0.45 |
| Price / Sales | 12.42 |
| Altman Z-Score | -1.31 (distress) |
| Sector P/E (Healthcare) | 21.7 |
IMA overview · IMA earnings · IMA KPIs · IMA investor relations · IMA ownership · IMA peers · IMA filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.